Sector pending / Health ServicesUpdated 2026-05-10 22:07 UTC

FRA/D9Z stock hub

FRA/D9Z has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/D9Zis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

893.8M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/D9ZFRA/D9Z

—

Loading chart…

In the news

Latest news · FRA/D9Z

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E21.3

P25 n/aP50 n/aP75 n/a

ROE41

P25 n/aP50 n/aP75 n/a

ROIC34.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/D9Z market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

EUR

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Spain
Country code	DE
Employees	1,910
Employees Change	151%
Employees Change Percent	8.58
Enterprise value	EUR 913.6M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Health Services
Last refreshed	2026-05-10
Market cap	EUR 893.8M
Price	EUR 56.4
Price currency	EUR
Rev Per Employee	191,525.16x
Sic	8000
Symbol	fra/D9Z
Website	https://www.clinicabaviera.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.71%
EV Earnings	21.72x
EV/EBIT	15.06x
EV/EBITDA	11.03x
EV/FCF	19.51x
EV/Sales	3x
FCF yield	5.24%
P/B ratio	8.06x
P/E ratio	21.25x
P/S ratio	2.93x
PE Ratio10 Y	14.69x
PE Ratio3 Y	13.27x
PE Ratio5 Y	12.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.89%
EBITDA Margin	27.15%
FCF margin	15.36%
Gross margin	49.52%
Gross Profit	EUR 151M
Gross Profit Growth	13.91%
Gross Profit Growth Q	15.36%
Gross Profit Growth3 Y	14%
Gross Profit Growth5 Y	20.92%
Net Income	EUR 42.1M
Net Income Growth	4.62%
Net Income Growth Q	12.98%
Net Income Growth3 Y	12.53%
Net Income Growth5 Y	24.71%
Pretax Margin	19.71%
Profit Margin	13.8%
Profit Per Employee	EUR 26,421
ROA	16.48
Roa5y	18.23
ROCE	32.59
ROE	41.02
Roe5y	46.87
ROIC	34.66
Roic5y	39.32

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	31.15%
Cagr15y	17.54%
Cagr1y	58.47%
Cagr3y	49.14%
Cagr5y	39.56%
Div CAGR10	20.69%
Div CAGR3	6.49%
Div CAGR5	23.25%
EPS Growth	4.54
EPS Growth Q	12.8
EPS Growth3 Y	13.2
EPS Growth5 Y	25.16
FCF Growth	30.08%
FCF Growth Q	6.12%
FCF Growth3 Y	5.97%
FCF Growth5 Y	14.65%
OCF Growth	22.93%
OCF Growth Q	30.9%
OCF Growth10 Y	21.64%
OCF Growth3 Y	12.91%
OCF Growth5 Y	19.56%
Revenue Growth	14.75x
Revenue Growth Q	10.62x
Revenue Growth3 Y	15.39x
Revenue Growth5 Y	19.98x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.33
Assets	EUR 247.5M
Cash	EUR 50.3M
Current Assets	EUR 59.3M
Current Liabilities	EUR 61.5M
Debt	EUR 69.2M
Debt EBITDA	EUR 0.84
Debt Equity	EUR 0.62
Debt FCF	EUR 1.48
Equity	EUR 111M
Interest Coverage	26.58
Liabilities	EUR 136.6M
Long Term Assets	EUR 188.2M
Long Term Liabilities	EUR 75.1M
Net Cash	EUR -18.8M
Net Cash By Market Cap	EUR -2.11
Net Debt EBITDA	EUR 0.23
Net Debt Equity	EUR 0.17
Net Debt FCF	EUR 0.4
Tangible Book Value	EUR 69.9M
Tangible Book Value Per Share	EUR 4.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.97
Inventory Turnover	46.59
Net Working Capital	EUR -39.3M
Quick ratio	0.9
Working Capital	EUR -2.1M
Working Capital Turnover	EUR -126

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.08%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	EUR 1.27
Dividend Years	6
Dividend Yield	2.26%
Ex Div Date	2026-06-10
Last Dividend	EUR 1.27
Payout Frequency	Annual
Payout Ratio	59.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,404.49%
1Y total return	58.42%
200-day SMA	47.1
3Y total return	231.84%
50-day SMA	51.21
50-day SMA vs 200-day SMA	50over200
5Y total return	429.24%
All Time High	56.4
All Time High Change	0%
All Time High Date	2026-02-09
All Time Low	2.96
All Time Low Change	1,803.48%
All Time Low Date	2012-05-29
ATR	1.02
Ch YTD	14.63
High	56.4
High52	56.4
High52 Date	2026-05-07
High52ch	0%
Low	55.8
Low52	36.5
Low52 Date	2025-05-07
Low52ch	54.52%
Ma50ch	10.14%
Price vs 200-day SMA	19.74%
RSI	70.63
RSI Monthly	72.78
RSI Weekly	66.5
Sharpe ratio	1.46x
Sortino ratio	2.73
Total Return	2.18%
Tr YTD	14.63
Tr15y	1,029.75%
Tr1m	17.26%
Tr1w	1.08%
Tr3m	8.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 60.6M
Operating Income Growth	8.97
Operating Income Growth Q	7.52
Operating Income Growth3 Y	13.06
Operating Income Growth5 Y	25.05
Operating margin	19.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,186,226%
Net Borrowing	-9,855,016
Shares Insiders	1.79%
Shares Institutions	6.97%
Shares Qo Q	0.04%
Shares Yo Y	0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 46.8M
Average Volume	12.55x
Bv Per Share	6.87
CAPEX	EUR -30M
Ch10y	975.7
Ch15y	602.4
Ch1m	17.26
Ch1w	1.08
Ch1y	53.68
Ch3m	8.05
Ch3y	198.4
Ch5y	333.8
Ch6m	37.56
Change	0%
Change From Open	1.08
Close	56.4
Days Gap	-1.06
Depreciation Amortization	22,132,385
Dollar Volume	112.8
Earnings Date	2026-05-26
EBIT	EUR 60.6M
EBITDA	EUR 82.8M
EPS	EUR 2.63
F Score	5
FCF	EUR 46.8M
FCF EV Yield	5.13x
Financing CF	-36,454,262
Fiscal Year End	December
Founded	1,992
Goodwill	29,007,779
Graham Number	20.4473
Graham Upside	-63.75
Income Tax	EUR 17.2M
Investing CF	-45,016,537
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	EUR 65.59
Lynch Upside	16.3
Ma150	48.07
Ma150ch	17.32%
Ma20	53.03
Ma20ch	6.35%
Net CF	-4,550,666
Next Earnings Date	2026-05-26
Open	55.8
P FCF Ratio	19.09
P OCF Ratio	11.63
Payment Date	2026-06-12
Position In Range	100
Ppne	143,140,220
Price Date	2026-05-08
Price EBITDA	EUR 10.8
Ptbv Ratio	12.79
Relative Volume	0.16x
Revenue	304,908,056x
Tax By Revenue	5.63x
Tax Rate	28.57%
Tr6m	37.56%
Volume	2
Z Score	5.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/D9Z dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$1.27 annual per share

Payout ratio

+59.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+23.3%

0 consecutive years of growth

Total shareholder yield

+2.2%

Next ex-dividend date: 2026-06-10

Performance

FRA/D9Z stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/D9Z?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.0%

Share of float held by funds and institutions

Insider ownership

+1.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/D9Z momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.6

Above 70: short-term overbought

Price vs 200-day MA

+19.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/D9Z

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/D9Z stock rating?

fra/D9Z is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/D9Z analysis?

The full report lives at /stocks/fra/D9Z/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/D9Z?

The latest report frames fra/D9Z around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/D9Z page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.